Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3271
-0.0112-3.31%
Volume:459.30K
Turnover:145.61K
Market Cap:23.25M
PE:-0.88
High:0.3300
Open:0.3300
Low:0.3069
Close:0.3383
Loading ...

Ovid Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $2 From $3

THOMSON REUTERS
·
24 Mar

William Blair Sticks to Their Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
12 Mar

Ovid Therapeutics’ Cybersecurity Challenges: Navigating IT Risks and Third-Party Dependencies

TIPRANKS
·
12 Mar

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
11 Mar

Ovid Therapeutics Q4 2024 GAAP EPS $(0.13) Beats $(0.16) Estimate, Sales $76K Miss $189.286K Estimate

Benzinga
·
11 Mar

Press Release: Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
11 Mar

We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate

Simply Wall St.
·
11 Mar

Ovid Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
04 Mar

BRIEF-Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors

Reuters
·
03 Mar

Ovid Therapeutics appoints Papadopoulos to board of directors

TIPRANKS
·
03 Mar

Ovid Therapeutics Appoints Pioneering Industry Leader DR. Stelios Papadopoulos to Board of Directors

THOMSON REUTERS
·
03 Mar

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

GlobeNewswire
·
03 Mar

BRIEF-Ovid Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance

Reuters
·
14 Feb

Ovid Therapeutics Inc - Receives Nasdaq Notice for Minimum Bid Price Non-Compliance

THOMSON REUTERS
·
14 Feb

Oppenheimer Upgrades Ovid Therapeutics to Outperform From Perform, $4 Price Target

MT Newswires Live
·
29 Jan

Ovid Therapeutics Insider Ups Holding During Year

Simply Wall St.
·
23 Jan

3 US Penny Stocks With Market Caps Over $20M

Simply Wall St.
·
14 Dec 2024

ANALYSIS-RFK Jr vow to purge FDA sets up collision with Big Pharma

Reuters
·
15 Nov 2024

Ovid Therapeutics Inc reports results for the quarter - Earnings Summary

Reuters
·
12 Nov 2024

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
12 Nov 2024